IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD
Pm. Parker et al., IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD, Blood, 88(10), 1996, pp. 3805-3805